Ontology highlight
ABSTRACT: Importance
The prognosis of advanced pancreaticobiliary tumors is poor. Next-generation sequencing (NGS) of tissue samples is utilized to identify actionable alterations, but there are occasional limitations due to inadequate tissue acquisition. Circulating tumor DNA (ctDNA) is an alternative method, but its correlation with tissue-based NGS remains unexplored.Objectives
To assess the mutation concordance (mCR) rates between ctDNA and tissue testing for patients with pancreatic ductal adenocarcinoma (PDAC) and cholangiocarcinoma (CC) and to evaluate how ctDNA performs as a treatment response biomarker.Design, setting, and participants
This retrospective cohort study was conducted among patients with PDAC and CC treated at academic institutions from January 2014 to J
SUBMITTER: Mahadevia H
PROVIDER: S-EPMC12432637 | biostudies-literature | 2025 Sep
REPOSITORIES: biostudies-literature